| 1 |
29958796 | Cyclophosphamide with or without fluorouracil followed by subcutaneous or intravenous interleukin-2 use in solid tumors: A feasibility off-label experience. | 2019 Jan |
1 |
| 2 |
30048737 | Development and utilization of a unique in vitro antigen presentation co-culture model for detection of immunomodulating substances. | 2018 Dec |
2 |
| 3 |
15888259 | Effects of interferon beta, cyclophosphamide and azathioprine on cytokine profile in patients with multiple sclerosis. | 2005 Apr-Jun |
2 |
| 4 |
9673353 | Augmentation of IL-2 activated natural killer cell adoptive immunotherapy with cyclophosphamide. | 1998 May-Jun |
1 |
| 5 |
9829841 | Adjuvant treatment of breast cancer: a pilot immunochemotherapy study with CMF, interleukin-2 and interferon alpha. | 1998 Nov |
1 |
| 6 |
7481481 | Longitudinal study on the production of and cellular response to interleukin-2 in patients with systemic lupus erythematosus. | 1995 |
1 |
| 7 |
8563240 | Interleukin-2 therapy of Langerhans cell histiocytosis. | 1995 Oct |
1 |
| 8 |
8399071 | Immunomodulation of interleukin-2 by cyclophosphamide: a phase IB trial. | 1993 Jul |
7 |
| 9 |
8507545 | Cellular interaction against autologous tumor cells between IL-2-cultured lymphocytes and fresh peripheral blood lymphocytes in patients with breast cancer given immuno-chemotherapy. | 1993 |
1 |
| 10 |
1526289 | Chemoimmunotherapy of cancer: cyclophosphamide-resistant tumour cells are equally sensitive as the original tumour cell population to local IL-2 immunotherapy. | 1992 |
1 |
| 11 |
1629914 | Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinoma. | 1992 Jun 17 |
4 |
| 12 |
1910623 | Continuous infusion of interleukin-2 and cyclophosphamide as treatment of advanced cancers: a National Biotherapy Study Group Trial. | 1991 Jun |
1 |
| 13 |
1944193 | [Splenic or hepatic arterial injections of interleukin-2 with chemotherapeutic agents for hepatic metastases]. | 1991 Sep |
1 |
| 14 |
2400994 | Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitro. | 1990 Oct 1 |
1 |
| 15 |
2785408 | Myelostimulatory activity of recombinant human interleukin-2 in mice. | 1989 May 1 |
1 |
| 16 |
2787392 | Tumor-infiltrating lymphocytes cultured in recombinant interleukin-2: enhancement of growth, cytotoxicity, and phenotypic expression of cytotoxic T-cell antigens by cyclophosphamide given intravenously prior to tumor harvest. | 1989 Jun |
1 |
| 17 |
3138120 | Effects of cimetidine on interleukin-2 production by peripheral blood lymphocytes in advanced ovarian carcinoma. | 1988 Jul |
1 |
| 18 |
3257158 | Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide. | 1988 Jan 1 |
7 |
| 19 |
3496854 | [Antitumor action of interleukin 2 and its biological activities]. | 1987 Jun |
1 |
| 20 |
2412956 | The treatment of induced immune deficiency with interleukin-2. | 1985 |
1 |
| 21 |
6334134 | Expansion of murine cytotoxic precursors in vitro and in vivo by purified interleukin-2. | 1984 Oct |
2 |
| 22 |
6610060 | Rescue of anti-influenza A virus cytotoxic T-lymphocyte responses in chemotherapy-suppressed mice. | 1984 Jul |
1 |
| 23 |
6134774 | Expansion of cyclophosphamide-resistant cytotoxic precursors in vitro and in vivo by purified human interleukin 2. | 1983 Aug |
4 |